eHealth Ventures are happy to sponsor Rise with US, an intensive 4 week hybrid program introducing selected Israeli entrepreneurs and early-stage startups working on digital and computational health solutions for meetings with customers, investors, and service providers, to the US healthcare market.
CEO & Co-Founder at AccuLine, Moshe Barel is saying, “The ‘Rise’ program contributed a lot to me and the company by providing me with extensive knowledge about the American market in a concentrated, fast, and orderly manner. Thanks to this knowledge, the company will be able to be more focused on entering the American market and will thereby save a great deal of time and money.
Dr. Amir Beker, Co-founder and CEO of Identifai-Genetics, shared with us that “The program allowed us close acquaintance with the space of healthcare services, health technologies and biomedical research in the Philadelphia area. We did not know this ecosystem, which super-active and rich in content, and it can provide a comprehensive view and integrated action in US market penetration phase.
The program also clarified challenges involved in penetrating the US healthcare market and their possible solutions, and introduced us to important players in the field, such as leading medical centers (e.g. Jefferson Health), medical insurers (Blue Cross), and research centers.”
Ophir Shahaf, VP Business Development at eHealth Ventures Incubator, is saying “eHealth Ventures has invested in a wide portfolio of digital health companies, of which 10 are in the commercial phase. Part of the clear added value we provide these companies is connecting them to their target markets: leading medical centers, customers, partners and investors. Our critical mass, combined with the deep ecosystem knowledge and connections of “Philadelphia Science Center” make the RISE with US program an ideal platform for exposing our companies in this attractive target market”.
About eHealth Ventures
The eHealth Ventures partnership is a leading investor in early-stage digital health companies.
It includes 2 VC funds and a technological incubator with an exclusive focus on digital health and significant government non-dilutive funding. Partners include Maccabi (a leading Israeli HMO), Amgen (global biotech giant), the Mayo Clinic, Medison Ventures, Arad Investments, and the Hadar Group. The team has reviewed over 1,650 companies to date and invested in a portfolio of 24 highly innovative companies (digital diagnostics, therapeutics, home care and Bioconvergence).